Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold J Manley

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Journal of Managed Care Pharmacy : JMCP|February 22, 2008
Disease progression and the application of evidence-based treatment guidelines diagnose it early: a case for screening and appropriate managementHarold J Manley
Pharmacotherapy|July 20, 2002
Darbepoetin-alpha: a review of the literatureDebra K Overbay, Harold J Manley
Nephrology News & Issues|February 19, 2005
Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patientsHarold J Manley, Carrie A Cannella
Seminars in Dialysis|February 7, 2008
Vancomycin use in patients requiring hemodialysis: a literature reviewKatie E Pallotta, Harold J Manley
Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|September 12, 2008
Smoking cessation therapy considerations for patients with chronic kidney diseaseHarold J Manley, Nicole M Stack
Pharmacotherapy|July 30, 2003
Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysisHarold J Manley, Nicole M Allcock
Nephrology News & Issues|April 2, 2004
Providing free medications to dialysis patients. A description of a multidisciplinary team medication sampling and patient assistance programDebra K Drayer, Harold J Manley
BMC Nephrology|January 14, 2004
Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro studyHarold J Manley, Darren W Grabe
Seminars in Dialysis|March 5, 2002
The clinical and economic impact of pharmaceutical care in end-stage renal disease patientsHarold J Manley, Cathryn A Carroll
Seminars in Dialysis|November 20, 2002
Treatment of peritonitis in APD: pharmacokinetic principlesHarold J Manley, George R Bailie
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of Managed Care Pharmacy : JMCP|February 22, 2008
Disease progression and the application of evidence-based treatment guidelines diagnose it early: a case for screening and appropriate managementHarold J Manley
Pharmacotherapy|July 20, 2002
Darbepoetin-alpha: a review of the literatureDebra K Overbay, Harold J Manley
Nephrology News & Issues|February 19, 2005
Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patientsHarold J Manley, Carrie A Cannella
Seminars in Dialysis|February 7, 2008
Vancomycin use in patients requiring hemodialysis: a literature reviewKatie E Pallotta, Harold J Manley
Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|September 12, 2008
Smoking cessation therapy considerations for patients with chronic kidney diseaseHarold J Manley, Nicole M Stack
Pharmacotherapy|July 30, 2003
Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysisHarold J Manley, Nicole M Allcock
Nephrology News & Issues|April 2, 2004
Providing free medications to dialysis patients. A description of a multidisciplinary team medication sampling and patient assistance programDebra K Drayer, Harold J Manley
BMC Nephrology|January 14, 2004
Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro studyHarold J Manley, Darren W Grabe
Seminars in Dialysis|March 5, 2002
The clinical and economic impact of pharmaceutical care in end-stage renal disease patientsHarold J Manley, Cathryn A Carroll
Seminars in Dialysis|November 20, 2002
Treatment of peritonitis in APD: pharmacokinetic principlesHarold J Manley, George R Bailie
Pageof 7